Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 10.8% on 9/11/25. The shares closed at $7.77. Moreover, this advance was accompanied by exceptionally high trading volume at 223% of normal. The stock has been strong relative to the market over the last nine months and has risen 0.8% during the last week.
Current PriceTarget Research Rating
Lifecore Biomedical has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Lifecore Biomedical has a very low Appreciation Score of 0 but a good Power Rating of 78, producing the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment